SCHEIN PHARMACEUTICAL INC
SC 14D9/A, EX-99.(A)(5), 2000-06-22
PHARMACEUTICAL PREPARATIONS
Previous: SCHEIN PHARMACEUTICAL INC, SC 14D9/A, 2000-06-22
Next: SCHEIN PHARMACEUTICAL INC, SC 14D9/A, EX-99.(A)(6), 2000-06-22



<PAGE>   1

ChaseMellon Shareholder Services, LLC
Reorganization Department
P.O. Box 3301
South Hackensack, NJ 07066

                           CONFIDENTIAL INSTRUCTIONS
                                      FOR
  OFFER TO PURCHASE FOR CASH ALL OUTSTANDING SHARES OF COMMON STOCK OF SCHEIN
                              PHARMACEUTICAL, INC.

THESE INSTRUCTIONS PERTAIN TO COMMON STOCK OF SCHEIN PHARMACEUTICAL, INC.
PURCHASED UNDER THE FOLLOWING PLANS (COLLECTIVELY, THE "PLANS"):

     1.  THE RETIREMENT PLAN OF SCHEIN PHARMACEUTICAL, INC. AND AFFILIATES
         ("401(k) PLAN");

     2.  SCHEIN PHARMACEUTICAL, INC. 1998 EMPLOYEE STOCK PURCHASE PLAN ("STOCK
         PURCHASE PLAN");

     3.  SCHEIN PHARMACEUTICAL, INC. 1993 STOCK OPTION PLAN ("1993 OPTION
         PLAN");

     4.  SCHEIN PHARMACEUTICAL, INC. 1995 NON-EMPLOYEE DIRECTORS STOCK OPTION
         PLAN ("1995 OPTION PLAN");

     5.  SCHEIN PHARMACEUTICAL, INC. 1997 STOCK OPTION PLAN ("1997 OPTION
         PLAN"); AND

     6.  SCHEIN PHARMACEUTICAL, INC. 1999 STOCK OPTION PLAN ("1999 OPTION
         PLAN").

  THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY
          TIME, ON MONDAY, JULY 3, 2000, UNLESS THE OFFER IS EXTENDED.

To Participants in the above listed Plans:

     Enclosed is a copy of the "Offer To Purchase For Cash All Outstanding
Shares of Common Stock of Schein Pharmaceutical, Inc." by Watson
Pharmaceuticals, Inc., through its wholly owned subsidiary, WS Acquisition
Corp., and the related "Letter of Transmittal" (which, together with any
amendments or supplements thereto, collectively constitute the "Offer"), and two
Instruction Letters relating to the Offer. Also enclosed is an instructional
memorandum regarding options issued under the several option plans. This
material is being forwarded to you as the beneficial owner of shares of common
stock of Schein Pharmaceutical, Inc. (the "Shares") held by you through, or
purchased under, one or more of the Plans. A tender of such Shares into the
Offer can be made only by us, acting in our capacity as depositary for the
Offer, pursuant to your instructions.

     We request confidential instructions as to whether you wish to have us
tender on your behalf any or all of such Shares held in the Plans, upon the
terms and subject to the conditions set forth in the Offer. TO TENDER SHARES
HELD UNDER THE PLANS, WE MUST RECEIVE FROM YOU THE APPROPRIATE INSTRUCTION CARD
OR TRANSMITTAL LETTER BY 5:00 P.M. NEW YORK CITY TIME ON THURSDAY, JUNE 29,
2000, UNLESS EXTENDED.

     Information relating to the tender of your Shares will be maintained in
confidence, except to the extent necessary to comply with federal or state laws.

401(k) PLAN

     You are entitled under the 401(k) Plan to tender any percentage of Shares
held in your account under the 401(k) Plan (regardless of whether you are fully
vested in your account). ChaseMellon Shareholder Services has been designated by
the trustee for the 401(k) Plan, American Express Trust Co., to receive your
election to tender the Shares held in your account under the 401(k) Plan. If you
wish to have any or all of your Shares held in your account tendered under the
401(k) Plan, please sign and send to us the enclosed PINK Instruction Letter.
ChaseMellon Shareholder Services will forward your election to the trustee who
will
<PAGE>   2

formally direct ChaseMellon Shareholder Services to tender such Shares, but
solely to the extent such Shares are held in your account under the 401(k) Plan
as of MONDAY, JULY 3, 2000 (OR SUCH LATER DATE IF THE PERIOD OF THE OFFER IS
EXTENDED).

     The proceeds from the tender of the Shares held in your account under the
401(k) Plan will be automatically reinvested in the American Express Trust
Income Fund II that is available under the 401(k) Plan. You may change such
investment amongst the investment alternatives available under the 401(k) Plan
at any time after the cash from the sale of the Shares has been credited to your
account under the 401(k) Plan.

     If you do not return the enclosed pink Instruction Letter the Trustee for
the 401(k) Plan will not tender any of the Shares held in your account under the
401(k) Plan.

     ChaseMellon Shareholder Services, LLC and the Trustee will hold all
information in confidence and will not divulge it to any party, except as
otherwise required to administer the Plan, to effect your tender or as required
by law.

STOCK PURCHASE PLAN

     If you wish to have us tender any or all of the Shares held in your account
under the Stock Purchase Plan, please sign and send to us the enclosed PURPLE
Instruction Letter. If you do not return the enclosed purple Instruction Letter
we will not tender any of the Shares held in your account under the Stock
Purchase Plan.

STOCK OPTION PLANS

     If you wish to have us tender any or all of the Shares underlying your
vested stock options granted under any of the 1993 Option Plan, [the 1995 Option
Plan], the 1997 Option Plan and the 1999 Option Plan (collectively, the "Option
Plans"), please sign and send to us the enclosed BLUE Letter of Transmittal in
the envelope marked Stock Option Only. If you do not return the enclosed blue
Letter of Transmittal we will not tender any of the Shares underlying your
vested stocks granted under one or more of the Stock Option Plans. You must also
call ChaseMellon Shareholder Services at (800) 411-6657 no later than 8:00 P.M.,
New York City time, Wednesday, June 28, 2000 to exercise the vested stock
options that you wish to tender.

     By tendering any or all of the Shares underlying your vested stock options,
you will be deemed to have elected to exercise your vested stock options (to the
extent tendered) by a "cashless exercise." Pursuant to the "cashless exercise,"
the exercise price for the number of Shares being deemed to be purchased under
your stock options will be financed through the immediate sale of that number of
Shares from the stock option being exercised necessary to satisfy the payment of
the total required exercise price for the Shares being purchased plus any
withholding taxes.

     TO TENDER SHARES HELD UNDER THE PLANS, WE MUST RECEIVE FROM YOU THE
APPROPRIATE INSTRUCTION CARD OR TRANSMITTAL LETTER BY 5:00 P.M. NEW YORK CITY
TIME ON THURSDAY, JUNE 29, 2000, UNLESS EXTENDED.

     IF WE DO NOT RECEIVE A PROPERLY EXECUTED INSTRUCTION CARD OR TRANSMITTAL
LETTER FROM YOU, WE WILL NOT TENDER YOUR SHARES INTO THE OFFER.

                                        2
<PAGE>   3

                               INSTRUCTION LETTER
       THE RETIREMENT PLAN OF SCHEIN PHARMACEUTICAL, INC. AND AFFILIATES
                              (THE "401(k) PLAN")

To ChaseMellon Shareholder Services, LLC:

     I am a participant in the 401(k) Plan and, as such, I received a copy of
the Offer to Purchase, dated June 6, 2000, from Watson Pharmaceuticals, Inc.,
through its wholly owned subsidiary, WS Acquisition Corp., to purchase shares of
common stock of Schein Pharmaceutical, Inc. (the "Shares") for $19.50 per share
in cash.

     I hereby direct you to:

     [ ]  Tender all Shares held in my account under the 401(k) Plan at $19.50
          per share.

     [ ]  Tender only      % (insert percentage) Shares held in my account under
          the 401(k) Plan.

TO TENDER SHARES HELD UNDER THE PLANS, WE MUST RECEIVE FROM YOU THE APPROPRIATE
INSTRUCTION CARD OR TRANSMITTAL LETTER BY 5:00 P.M. NEW YORK CITY TIME ON
THURSDAY, JUNE 29, 2000, UNLESS EXTENDED. IF YOU DO NOT RETURN THIS LETTER, THE
TRUSTEE FOR THE 401(k) PLAN WILL NOT TENDER ANY OF THE SHARES HELD IN YOUR
ACCOUNT UNDER THE 401(k) PLAN.

I understand that my instructions will be effective solely to the extent such
shares are held in your account under the 401(k) Plan as of MONDAY, JULY 3, 2000
(OR SUCH LATER DATE IF THE PERIOD OF THE OFFER IS EXTENDED). I also understand
that the proceeds from the tender of the Shares held in my account under the
401(k) Plan will be automatically reinvested in the American Express Trust
Income Fund II that is available under the 401(k) Plan.

------------------------------------------------------
Name of Participant (printed)

------------------------------------------------------
Address of Participant

------------------------------------------------------
Date
------------------------------------------------------
Signature of Participant

------------------------------------------------------
City, State, Zip Code of Participant

ChaseMellon Shareholder Services
Mailing Address:                            Overnight Address:

Fax Number (201) ???-????

If you should have any questions regarding the information included in this
package contact DF King at (212) ???-????.

                                        3
<PAGE>   4

                               INSTRUCTION LETTER
         SCHEIN PHARMACEUTICAL, INC. 1998 EMPLOYEE STOCK PURCHASE PLAN
                          (THE "STOCK PURCHASE PLAN")

To ChaseMellon Shareholder Services, LLC:

     I am a participant in the Stock Purchase Plan and, as such, I received a
copy of the Offer to Purchase, dated June 6, 2000, from Watson Pharmaceuticals,
Inc., through its wholly owned subsidiary, WS Acquisition Corp., to purchase
shares of common stock of Schein Pharmaceutical, Inc. (the "Shares") for $19.50
per share in cash.

     I hereby direct you to:


     [ ]  Tender all Shares held in my account under the Stock Purchase Plan.



     [ ]  Tender only ______ (insert number) Shares held in my account under the
Stock Purchase Plan.


     TO TENDER SHARES HELD UNDER THE PLANS, WE MUST RECEIVE FROM YOU THE
APPROPRIATE INSTRUCTION CARD OR TRANSMITTAL LETTER BY 5:00 P.M. NEW YORK CITY
TIME ON THURSDAY, JUNE 29, 2000, UNLESS EXTENDED. IF YOU DO NOT RETURN THIS
INSTRUCTION LETTER, WE WILL NOT TENDER ANY OF THE SHARES HELD IN YOUR ACCOUNT
UNDER THE STOCK PURCHASE PLAN.

------------------------------------------------------
Name of Participant (printed)

------------------------------------------------------
Address of Participant

------------------------------------------------------

Date



ChaseMellon Shareholder Services


Mailing Address:



Fax Number (201) ???-????

------------------------------------------------------
Signature of Participant

------------------------------------------------------
City, State, Zip Code of Participant

Overnight Address:

     If you should have any questions regarding the information included in this
package contact DF King at (212) ???-????.

                                        4


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission